Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rutkowski

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|March 16, 2026
Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and MemoryZehra E F Demir, AeRyon Kim, Beyzanur G Ak, et al.
Cancer Research|May 9, 2019
Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor-Positive Breast CancerClaire Buchta Rosean, Raegan R Bostic, Joshua C M Ferey, et al.
Journal of Visualized Experiments : Jove|April 22, 2014
Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancerMelanie R Rutkowski, Michael J Allegrezza, Nikolaos Svoronos, et al.
Immunity|September 20, 2014
Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expressionTom L Stephen, Melanie R Rutkowski, Michael J Allegrezza, et al.
Cancer Research|May 25, 2013
Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironmentJason R Baird, Barbara A Fox, Kiah L Sanders, et al.
Cancer Research|November 3, 2016
Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological MyelopoiesisMichael J Allegrezza, Melanie R Rutkowski, Tom L Stephen, et al.
Cancer Immunology Research|February 11, 2025
TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy against Ovarian CancerMitchell T McGinty, Audrey M Putelo, Sree H Kolli, et al.
The Journal of Experimental Medicine|February 22, 2012
Ovarian cancer progression is controlled by phenotypic changes in dendritic cellsUciane K Scarlett, Melanie R Rutkowski, Adam M Rauwerdink, et al.
Cancer Immunology Research|August 30, 2022
Reciprocal Interactions Between the Gut Microbiome and Mammary Tissue Mast Cells Promote Metastatic Dissemination of HR+ Breast TumorsTzu-Yu Feng, Francesca N Azar, Sally A Dreger, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Ovarian Cancer Drives TLR5-Dependent Expansion of Myeloid Progenitors Through Systemic Dissemination of LigandsSree H Kolli, Mitchell T McGinty, Audrey M Putelo, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|March 16, 2026
Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and MemoryZehra E F Demir, AeRyon Kim, Beyzanur G Ak, et al.
Cancer Research|May 9, 2019
Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor-Positive Breast CancerClaire Buchta Rosean, Raegan R Bostic, Joshua C M Ferey, et al.
Journal of Visualized Experiments : Jove|April 22, 2014
Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancerMelanie R Rutkowski, Michael J Allegrezza, Nikolaos Svoronos, et al.
Immunity|September 20, 2014
Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expressionTom L Stephen, Melanie R Rutkowski, Michael J Allegrezza, et al.
Cancer Research|May 25, 2013
Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironmentJason R Baird, Barbara A Fox, Kiah L Sanders, et al.
Cancer Research|November 3, 2016
Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological MyelopoiesisMichael J Allegrezza, Melanie R Rutkowski, Tom L Stephen, et al.
Cancer Immunology Research|February 11, 2025
TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy against Ovarian CancerMitchell T McGinty, Audrey M Putelo, Sree H Kolli, et al.
The Journal of Experimental Medicine|February 22, 2012
Ovarian cancer progression is controlled by phenotypic changes in dendritic cellsUciane K Scarlett, Melanie R Rutkowski, Adam M Rauwerdink, et al.
Cancer Immunology Research|August 30, 2022
Reciprocal Interactions Between the Gut Microbiome and Mammary Tissue Mast Cells Promote Metastatic Dissemination of HR+ Breast TumorsTzu-Yu Feng, Francesca N Azar, Sally A Dreger, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Ovarian Cancer Drives TLR5-Dependent Expansion of Myeloid Progenitors Through Systemic Dissemination of LigandsSree H Kolli, Mitchell T McGinty, Audrey M Putelo, et al.
Pageof 14